GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Price-to-Tangible-Book

Acerus Pharmaceuticals (TSX:ASP) Price-to-Tangible-Book : (As of Jun. 20, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Acerus Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-06-20), Acerus Pharmaceuticals's share price is C$0.36. Acerus Pharmaceuticals's Tangible Book per Share of Sep. 2022 for the quarter that ended in Sep. 2022 was C$-8.75. Hence, Acerus Pharmaceuticals's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Acerus Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

TSX:ASP's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.3
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Acerus Pharmaceuticals's share price is C$0.36. Acerus Pharmaceuticals's Book Value per Sharefor the quarter that ended in Sep. 2022 was C$-2.41. Hence, Acerus Pharmaceuticals's P/B Ratio of today is .


Acerus Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Acerus Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acerus Pharmaceuticals Price-to-Tangible-Book Chart

Acerus Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.91 - - 47.06 -

Acerus Pharmaceuticals Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Acerus Pharmaceuticals's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Acerus Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acerus Pharmaceuticals's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acerus Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Acerus Pharmaceuticals's Price-to-Tangible-Book falls into.



Acerus Pharmaceuticals Price-to-Tangible-Book Calculation

Acerus Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2022 )
=0.36/-8.745
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Acerus Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Acerus Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Acerus Pharmaceuticals (TSX:ASP) Business Description

Traded in Other Exchanges
N/A
Address
7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
Executives
Norma Beauchamp Director
Stephen Robert Gregory Director
Edward Joseph Gudaitis Director, Senior Officer

Acerus Pharmaceuticals (TSX:ASP) Headlines